Back to search
Immune Defect
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Immune Defect trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Immune Defect trials you may qualify forChediak-Higashi syndrome (CHS) is a rare autosomal recessive disorder characterized in its classical form by oculocutaneous albinism, a bleeding diathesis, recu…
Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common…
This protocol aims to gather information about sphingosine phosphate lyase insufficiency syndrome (SPLIS), also known as NPHS14, and to create a SPLIS patient r…
This multisite study seeks to understand whether and how pulse oximeter accuracy varies across children with different skin colors in real world clinical settin…
The major role of human genetic factors in the immune response to infections is now well established, particularly for viral infections. In the context of the C…
The goal of this observational study is to learn about the role of immune cells in patients with diabetes and chronic foot ulcers. Researchers will compare bloo…
This is a national, prospective study designed to investigate the genetic etiologies of non-immune hydrops fetalis (NIHF) and other birth defects. At least half…
This is a phase 3, randomized, multicenter, double-masked, parallel group, vehicle-controlled prospective clinical trial to evaluate the safety and efficacy of…
The investigators have recently evidenced the presence of antibodies to endothelial cells and fibroblasts in patients with idiopathic or SSc-associated PAH. The…